Butyrophenones Interactions

Cabergoline should not be administered concurrently with butyrophenones, which are D2-antagonists that may antagonize cabergoline's dopaminergic effects.

Source: NLP:cabergoline

Potentiates CNS-depressant action of clonazepam.

Source: NLP:clonazepam

May reduce or reverse the pressor effect of epinephrine; concurrent use should be avoided but careful monitoring is essential if necessary.

Source: NLP:articaine hydrochloride and epinephrine

May reduce or reverse the pressor effect of epinephrine; concurrent use should generally be avoided but if necessary requires careful patient monitoring.

Source: NLP:articaine hydrochloride, epinephrine bitartrate

May reduce or reverse the pressor effect of epinephrine in local anesthetic solutions.

Source: NLP:bupivacaine hydrochloride

May reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided; if necessary, careful patient monitoring is essential.

Source: NLP:bupivacaine hydrochloride and epinephrine bitartrate

Dopamine D2 receptor antagonists may reduce the therapeutic effects of levodopa; patients should be carefully observed for loss of therapeutic response.

Source: NLP:carbidopa

Dopamine D2 receptor antagonists may reduce the therapeutic effects of levodopa; patients should be carefully observed for loss of response.

Source: NLP:carbidopa and levodopa

Dopamine D2 receptor antagonists may reduce therapeutic effects of levodopa.

Source: NLP:carbidopa, levodopa and entacapone

May reduce or reverse the pressor effect of epinephrine in lidocaine solutions; concurrent use should generally be avoided.

Source: NLP:lidocaine hydrochloride

Butyrophenones may reduce or reverse the pressor effect of epinephrine. Concurrent use should generally be avoided.

Source: NLP:lidocaine, kenalog, povidone iodine

May reduce or reverse the pressor effect of epinephrine in mepivacaine solutions.

Source: NLP:mepivacaine hydrochloride

Dopamine antagonists may diminish the effectiveness of pramipexole dihydrochloride.

Source: NLP:pramipexole dihydrochloride

Neuroleptic dopamine antagonist that may reduce the efficacy of ropinirole extended-release tablets.

Source: NLP:ropinirole

Neuroleptic dopamine antagonists that may reduce the efficacy of ropinirole tablets.

Source: NLP:ropinirole hydrochloride

May reduce or reverse the pressor effect of epinephrine in local anesthetic solutions. Concurrent use should generally be avoided.

Source: NLP:bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine